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Biﬁdobacteria are gut commensal microorganisms belonging to the Actinobacteria group. Some speciﬁc
strains of Biﬁdobacterium animalis subsp. lactis are used in functional foods as they are able to exert
health-promoting effects in the human host. Due to the limited genetic variability within this subspecies,
it is sometimes difﬁcult for a manufacturer to properly track its strain once included in dairy products or
functional foods. In this paper, we present a peptidome-based analysis in which the proteomes of a set of
B. animalis subsp. lactis strains were digested in silico with human gut endopeptidases. The molecular
masses were compared along all the strains to detect strain-speciﬁc peptides. These peptides may be
interesting towards the development of methodologies for strain identiﬁcation in the ﬁnal product.
© 2016 Elsevier Ltd. All rights reserved.Biﬁdobacteria are members of the, one of the main microbial
taxa of the human gut microbiota. Their abundance varies
depending on age, being one of the most prevalent microorganisms
in newborns and infants. In addition, members of the species Biﬁ-
dobacterium longum, Biﬁdobacterium breve, Biﬁdobacterium biﬁdum
and Biﬁdobacterium animalis have been used as probiotics due to
the scientiﬁc evidence of speciﬁc beneﬁcial effects on the human
host (Hill et al., 2014).
Within B. animalis, B. animalis subsp. lactis receives particular
attention, due to its capacity to grow and survive in milk, and some
strains such as CNCM I-2494 have been included as adjunct cultures
of fermented milks since 1987 (Chervaux et al., 2011). This sub-
species is by far the biﬁdobacteria more used in functional food
products (Gueimonde et al., 2004), and it is usually the sole viable
biﬁdobacteria species in fermented milks (Jayamanne and Adams,
2006). This is mainly due to the intrinsic resistance of this species
to both technological and physiological stresses (Jayamanne and
Adams, 2006), being moderately aerotolerant and able to adapt to
both acidic and bile stress (Ruiz et al., 2012; Sanchez et al., 2007).
Among the reported beneﬁts of the strains of this species are).decrease of serum cholesterol levels, protection against colorectal
cancer, regulation of the gut transit time and constipation, and
reduction of gut inﬂammation by maintaining a favorable balance
of the microbiota (Tabbers et al., 2011; Veiga et al., 2010). In addi-
tion, B. animalis subsp. lactis is the biﬁdobacteria with higher
number of clinical studies supporting its health-promoting attri-
butes in gastrointestinal disorders and allergic processes (Agrawal
et al., 2009; Isolauri et al., 2000; Weizman et al., 2005).
Multilocus sequence typing (MLST) showed that Biﬁdobacterium
animalis is phylogenetically distant from other species of the genus
(Deletoile et al., 2010). Indeed, strains belonging to B. animalis
subsp. lactis are difﬁcult to differentiate due to the high degree of
genome identity among strains (99.975%) (Lomonaco et al., 2015).
Proper strain identiﬁcation is a very valuable trait for both pro-
ducers and consumers, as close probiotic strains may have different
effects on host health, notably at the immunomodulation level (Hill
et al., 2014).
In recent years, multiple efforts have been focused on devel-
oping methods for strain differentiation within B. animalis subsp.
lactis. First attempts included application of relatively classical
techniques, such as pulse-ﬁeld gel electrophoresis, restriction
fragment length polymorphisms or MLST using housekeeping
genes such as gyrB or rpoB (Briczinski and Roberts, 2006; Deletoile
et al., 2010; Ventura and Zink, 2002). Later, the public availability of
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methods based on single nucleotide polymorphisms and insertion-
deletion polymorphisms (Briczinski et al., 2009; Lomonaco et al.,
2015; Tmanova et al., 2012). Alternatively, a number of mass
spectrometry strategies have also been proposed in order to offer a
more rapid analysis, higher reproducibility and more accurate re-
sults at species and strain levels (PMID: 26510657, 26537565,
26300860). In particular, previous works show that protein bio-
markers are able to accurately differentiate B. animalis strains at the
subspecies level (PMID: 22365357, 22417598, 21598393).
In this work, we evaluate the discriminative availability of an in
silico proteomic analysis of B. animalis strains, i.e. a fully compu-
tational analysis based on public mass spectra and free software.
The aim is to be able to generate a valid and manageable list of
potentially speciﬁc peptides for each strain, which can be further
investigated using in vitro approaches, such as LC-MS/MS, towards
the identiﬁcation of biomarkers and the development of
application-speciﬁc detection methods.
We have obtained the bacterial proteomes of all the B. animalis
subsp. lactis strains whose genomes are completely sequenced and
available at the National Center for Biotechnology Information
(NCBI) servers (Table 1). All the sequence data used in this study
were retrieved from the BioProject collection of the NCBI, using the
public FTP site (ftp://ftp.ncbi.nih.gov/genomes/bacteria/) (Wheeler
et al., 2000). Peptidomes were basically obtained through the
following pipeline: i) retrieval of proteins encoded in the publicly
available and completely sequenced genomes, ii) in silico digestion
of proteins using human gut endopeptidases, and iii) comparison of
the peptides according to their theoretical mass (peaks) and sub-
sequent computation of consensus peak sets.
The subcellular localizations of the proteins were predicted
using the standalone version of the PSortB v3.0 tool, following the
developer guidelines (Yu et al., 2010). The molecular weight of the
peptides and isoelectric point of the proteins were calculated using
in-house customised scripts. Peptidomes were generated for each
strain using the open-source Java library mzJava from ExPASy
(http://mzjava.expasy.org), which supports in silico protein diges-
tion (Horlacher et al., 2015). For the purposes of the present anal-
ysis, three proteases representing the major intestinal
endoproteases were used: trypsin, chymotrypsin and pepsin (low
speciﬁcity model, ph > 2).
In order to reduce the proteomic data input we sampled the
peptidomes according to different parameters such as peptide
length, subcellular localization of the source protein and its iso-
electric point (see Supplementary Material 1). Two different data-
sets or subpeptidomes were used in our study: i) peptides longer
than 50 amino acids obtained from cytoplasmic proteins includedTable 1
Biﬁdobacterium strains used in this study. Genome and protein data were retrieved
from the BioProject collection of the NCBI.
Strain BioProject
Biﬁdobacterium adolescentis ATCC 15703 PRJNA16321
Biﬁdobacterium animalis subsp. lactis AD011 PRJNA19423
Biﬁdobacterium animalis subsp. lactis ATCC 27673 PRJNA215974
Biﬁdobacterium animalis subsp. lactis B420 PRJNA156973
Biﬁdobacterium animalis subsp. lactis BB-12 PRJNA42883
Biﬁdobacterium animalis subsp. lactis BLC1 PRJNA71815
Biﬁdobacterium animalis subsp. lactis Bi-07 PRJNA156975
Biﬁdobacterium animalis subsp. lactis Bl12 PRJNA186412
Biﬁdobacterium animalis subsp. lactis Bl-04 PRJNA32897
Biﬁdobacterium animalis subsp. lactis BS 01 PRJNA59607
Biﬁdobacterium animalis subsp. lactis CNCM I-2494 PRJNA67865
Biﬁdobacterium animalis subsp. lactis DSM 10140 PRJNA32893
Biﬁdobacterium animalis subsp. lactis HN019 PRJNA28807
Biﬁdobacterium animalis subsp. lactis V9 PRJNA32515in the pI range 4.5e5.5 (Cyto_50_more dataset), and ii) peptides
obtained from extracellular proteins (Extracellular dataset). The
rationale behind the selection of these two subpeptidomes was
XXX. These datasets corresponded to about 1000 different peptides
per strain (see Supplementary Material 2). These datasets were
submitted to an in-house compiled version of SPECLUST (Alm et al.,
2006), which enabled the identiﬁcation of representative and
reproducible peak masses in all spectral proﬁles. SPECLUST calcu-
lates the mass difference between two peaks taken from different
peak lists and determines if the two peaks are identical taking into
account some measurement uncertainty (s; set empirically to
3.0 Da). In addition, a pairwise cut-off parameter determines
whether a peptide is shared between two spectra. In our work, a
peak match score greater than 0.6 (corresponding to a 0.5 Da mass
difference) was set to consider two peak masses to be the same in
two different proﬁles.
Using this methodology a consensus table summarizing the
shared and differential peptides among the strains was obtained.
The consensus mass peptide matrix was translated into a binary
matrix (0’s and 1’s, representing absence or presence of a given
peptide mass respectively) in NEXUS ﬁle format. An in-house script
allowed us to retrieve the sequence of any differential peptide from
its position in the matrix, as well as the source protein and biﬁ-
dobacterium strain (see Fig. 1).
MrBayes, the model-based phylogenetic inference tool based in
Bayesian statistics, was utilized to generate consensus trees from
the NEXUS ﬁles (Huelsenbeck and Ronquist, 2001). Phylogeny was
inferred through the restriction data type implemented in MrBayes
(with state 0 or 1 representing the absence or presence of a
consensus peptide throughout all the strain peptidomes). A
majority-rule consensus tree (50%) was obtained after discardingFig. 1. Data workﬂow of the proposed peptidome-based strain comparison pipeline.
Fig. 2. Bayesian phylogenetic trees obtained with the “Cyto_50_more” (A) or the “Extracellular” (B) peptidome datasets.
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values of the analysis were not yet stabilized. Biﬁdobacterium
adolescentis ATCC 15703 was selected as outgroup for phylogenetictree rooting. The resulting peptide-based phylogenetic trees are
shown in Fig. 2, one corresponding to the “Cyto_50_more” sub-
peptidome (Fig. 2-A) and the other corresponding to the
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discrepancies regarding strain clusters nor in average branch sup-
port. However, the extracellular dataset was more resolutive in
terms of strain differentiation and branch lengths were higher in
comparison with the cytoplasmic tree. This is interesting, because
the extracellular subproteome contains many of the proteins sup-
porting beneﬁcial effects on the human host, notably in terms of
immunomodulation (Sanchez et al., 2010). For that reason, onemay
hypothesize that speciﬁc strains with speciﬁc beneﬁts harbor
unique extracellular proteins encoded within their genomes.
Compared to other molecular approaches, our peptidome-based
trees are fairly similar to those generated by single nucleotide
polymorphisms (SNP)/insertion-deletion polymorphism-based
allelic typing (Briczinski et al., 2009; Tmanova et al., 2012).
Brieﬂy, all strains were very close due to their high genetic simi-
larity with the exception of B. animalis subsp. lactis ATCC 27673,
which clustered apart with a 100% posterior probability. It has been
reported that strain ATCC 27673 harbors unique genome traits into
genomic islands, making this strain very different from the rest
(Loquasto et al., 2013).
There are two main hypotheses supporting our results that
indeed re-iterate previous ﬁndings from previous research. The
ﬁrst is that the high genetic similarity might be the result of a bias
in strain sequencing, notably the fact that almost all sequenced
strains come from commercial products; granted that the natural
reservoir of this species is not yet know, we would lack most of the
wild-type strains. The second is that it might be the consequence of
a recent adaptation of an ancestor strain to the dairy environment,
which would have eliminated many of the genetic diversity within
the subspecies, an assessment perfectly consistent with the
Founder effect theory of Population Genetics (Milani et al., 2013).
Given this scenario of high genetic similarity, it is very hard to ﬁnd
new polymorphisms among B. animalis subsp. lactis strains; indeed
occurrence of single nucleotide variants has been stimated in just
29 per 100 kb (Loquasto et al., 2013). Therefore, it is very difﬁcult for
an industry to differentiate its strain from the rest of competitors,
both in their stock cultures and in their ﬁnal products.
Within this context, our peptidome-based strategy is very
valuable, as a SNP may be silent. However, some SNPs can lead to
the generation of premature stop codons while others may cause a
frameshift and produce altered amino acid sequences. All these
changes have a direct reﬂect in the peptidomes, since proteins with
different amino acid content or with different length will produce
peptides with distinct molecular masses. All these potential dif-
ferences are detected by our analysis, granted that any changes in
the molecular mass of the peptides lead to a lack of consensus
among strains.
With our methodology, we have been able to identify speciﬁc
peptides in each of the strains included in our analysis. This was the
case of peptide SCATPPMNGMSSMAR, speciﬁc of the strain
B. animalis subsp. lactis DSM 10140 and encoded in long-chain-
fatty-acid-CoA ligase, a protein that can be detected in the cyto-
plasmic fraction. Other example is the peptide RSSARPTPPRRIRR-
SAVSNQQF, encoded in a small and extracellular hypothetical
protein of B. animalis subsp. lactis BB12. These are just two exam-
ples, but in fact more than 50 speciﬁc peptides per strain were
identiﬁed using our approach, both in the cytoplasmic and extra-
cellular proteomes (see Supplementary Material 3).
Knowledge on strain-speciﬁc peptides may facilitate the
development of methodologies focused on the detection of the
strain, e.g. in the ﬁnal product. This is a very interesting applied area
from the point of view of probiotic quality. Notably, antibody-based
tests targeting these speciﬁc peptides may efﬁciently detect a
deﬁned strain in fermented milks or within the gut microbiota
during clinical trials. This is extremely important in the case ofB. animalis subsp. lactis given its global distribution in human food
and low genetic variability. Therefore, we consider our peptidome-
based approach of practical and important relevance to the in-
dustry, with the advantage of minimal implementation re-
quirements and costs whilst providing considerable analysis power
and ﬂexibility.
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